MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, AIDX has $4,137,357 in assets. $4,156,582 in debts. $1,025,987 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
59.73%
Quick Ratio
55.01%
Cash Ratio
41.65%
Debt to Asset Ratio
100.46%
Unit: Dollar
Assets Breakdown
    • Deferred offering costs
    • Cash and cash equivalents
    • Right-of-use asset, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
1,025,987
Accounts receivable, net
199,954
Inventory
116,217
Prepaid expenses and other current assets
128,975
Total current assets
1,471,133
License agreement, net
271,143
Property and equipment, net
56,677
Intangible assets, gross
243,644
Less accumulated amortization
41,380
Intangible assets, net
202,264
Right-of-use asset, net
605,289
Deferred offering costs
1,507,794
Other assets
23,057
Total assets
4,137,357
Accounts payable
868,545
Accrued liabilities
785,784
Deferred revenue
414,871
Derivative liability
143,382
Convertible note
74,611
Operating lease liability current
175,948
Total current liabilities
2,463,141
Convertible notes payable, net
619,355
Deferred revenue long-term
41,816
Derivative liabilities long-term
543,545
Operating lease liability long term
488,725
Total long-term liabilities
1,693,441
Total liabilities
4,156,582
Preferred stock value-Series DPreferred Stock
1,016
Preferred stock value-Series CPreferred Stock
12,040
Preferred stock value-Series BPreferred Stock
14,715
Preferred stock value-Series A2Preferred Stock
4,424
Preferred stock value-Series A1Preferred Stock
6,515
Preferred stock value-Series APreferred Stock
8,464
Common stock, 0.01 par value 50,000,000 authorized 5,442,249 and 4,823,125 shares issued and outstanding as of december 31, 2025 and 2024, respectively
54,422
Additional paid-in capital
33,126,398
Accumulated deficit
-33,247,219
Total stockholders (deficit) equity
-19,225
Total liabilities and stockholders equity
4,137,357
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$1,025,987 Accounts receivable, net$199,954 Prepaid expenses andother current assets$128,975 Inventory$116,217 Intangible assets, gross$243,644 Deferred offering costs$1,507,794 Total current assets$1,471,133 Right-of-use asset, net$605,289 License agreement, net$271,143 Intangible assets, net$202,264 Property and equipment,net$56,677 Other assets$23,057 Less accumulatedamortization$41,380 Total assets$4,137,357 Accumulated deficit-$33,247,219 Total liabilities andstockholders equity$4,137,357 Total stockholders(deficit) equity-$19,225 Additional paid-in capital$33,126,398 Common stock, 0.01 parvalue 50,000,000...$54,422 Preferred stockvalue-Series BPreferred...$14,715 Preferred stockvalue-Series CPreferred...$12,040 Preferred stockvalue-Series APreferred...$8,464 Preferred stockvalue-Series A1Preferred...$6,515 Preferred stockvalue-Series A2Preferred...$4,424 Preferred stockvalue-Series DPreferred...$1,016 Total liabilities$4,156,582 Total currentliabilities$2,463,141 Total long-termliabilities$1,693,441 Accounts payable$868,545 Accrued liabilities$785,784 Deferred revenue$414,871 Operating lease liability current$175,948 Derivative liability$143,382 Convertible note$74,611 Convertible notes payable,net$619,355 Derivative liabilities long-term$543,545 Operating lease liability long term$488,725 Deferred revenue long-term$41,816

20 20 Biolabs, Inc. (AIDX)

20 20 Biolabs, Inc. (AIDX)